Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute of Human Virology Nigeria (IHVN) is a leading non-governmental organization established in 2004 to address the HIV/AIDS crisis in Nigeria through expanded treatment, care, and support. Affiliated with the Institute of Human Virology at the University of Maryland School of Medicine, IHVN has evolved into a multi-disease research and implementation powerhouse focusing on tuberculosis, malaria, COVID-19, and non-communicable diseases. The organization operates the International Research Center of Excellence (IRCE), which facilitates world-class laboratory research, clinical trials, and public health training. IHVN plays a critical role in the Nigerian healthcare landscape by partnering with the government to strengthen health systems and implement large-scale donor-funded programs. Its research portfolio includes significant contributions to genomics through the H3Africa initiative and longitudinal studies on HIV prevention and treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Human Virology Nigeria.